Pfizer agrees to pay $345 mln to resolve EpiPen pricing lawsuit

July 15 (Reuters) – Pfizer Inc (PFE.N) has agreed to pay $345 million to resolve claims by consumers who claim they overpaid for EpiPens due to anticompetitive and unfair practices by the drugmaker and the company that markets the emergency allergy treatment, Mylan. The proposed class action settlement was disclosed in a filing in federal court in […]

Inside the race to find a COVID-19 treatment pill

In early 2020, as a new deadly coronavirus began spreading around the world, Pfizer Inc (PFE.N) assembled what it called a “SWAT team” of scientists and chemists to identify a potential treatment to fight COVID-19.

IOC reassures anxious Japan Olympics will be safe

The International Olympic Committee (IOC) reassured an anxious Japan on Wednesday that the Tokyo Olympics would be safe for athletes as well as the host community, amid mounting opposition to the Games and fears it will fuel a spike in COVID-19 cases.